What the Research Says
Beta-sitosterol has a solid evidence base for BPH. A 1999 Cochrane-style review by Wilt et al. analyzing 4 RCTs (n=519) concluded that beta-sitosterol significantly improves urologic symptoms and flow measures in men with BPH. The landmark Berges 1995 Lancet trial remains the most cited, showing a 7.4-point IPSS improvement vs 2.9 for placebo. For cholesterol, a 2008 meta-analysis confirmed plant sterols reduce LDL by 8-10% at 2g/day.